UK markets closed

AbbVie Inc. (0QCV.IL)

IOB - IOB Delayed price. Currency in USD
Add to watchlist
161.58+2.24 (+1.41%)
At close: 07:14PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) 284.74B
Enterprise value 331.31B
Trailing P/E 47.42
Forward P/E 14.27
PEG ratio (5-yr expected) 0.42
Price/sales (ttm)5.19
Price/book (mrq)27.23
Enterprise value/revenue 6.09
Enterprise value/EBITDA 34.32

Trading information

Stock price history

Beta (5Y monthly) 0.47
52-week change 37.12%
S&P500 52-week change 322.38%
52-week high 3182.72
52-week low 392.98
50-day moving average 3173.50
200-day moving average 3157.74

Share statistics

Avg vol (3-month) 3154.91k
Avg vol (10-day) 3379.59k
Shares outstanding 51.77B
Implied shares outstanding 61.8B
Float 81.76B
% held by insiders 10.13%
% held by institutions 171.42%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 45.92
Forward annual dividend yield 44.05%
Trailing annual dividend rate 35.85
Trailing annual dividend yield 33.67%
5-year average dividend yield 44.84
Payout ratio 4118.93%
Dividend date 3N/A
Ex-dividend date 412 Oct 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Jun 2023

Profitability

Profit margin 15.50%
Operating margin (ttm)36.50%

Management effectiveness

Return on assets (ttm)9.18%
Return on equity (ttm)63.02%

Income statement

Revenue (ttm)56.02B
Revenue per share (ttm)31.65
Quarterly revenue growth (yoy)-4.90%
Gross profit (ttm)41.53B
EBITDA 29.2B
Net income avi to common (ttm)8.63B
Diluted EPS (ttm)4.86
Quarterly earnings growth (yoy)119.00%

Balance sheet

Total cash (mrq)8.77B
Total cash per share (mrq)4.97
Total debt (mrq)61.39B
Total debt/equity (mrq)475.99%
Current ratio (mrq)0.89
Book value per share (mrq)7.29

Cash flow statement

Operating cash flow (ttm)25.54B
Levered free cash flow (ttm)23.68B